Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Stellar Levy"'
Autor:
Camila Robles-Oteiza, Deborah Ayeni, Stellar Levy, Robert J. Homer, Susan M. Kaech, Katerina Politi
Publikováno v:
Disease Models & Mechanisms, Vol 14, Iss 11 (2021)
Conditional ablation of defined cell populations in vivo can be achieved using genetically engineered mice in which the human diphtheria toxin (DT) receptor (DTR) is placed under control of a murine tissue-specific promotor, such that delivery of DT
Externí odkaz:
https://doaj.org/article/d4f0aefa005e4a42a25399005ca41bcb
Autor:
Deborah Ayeni, Braden Miller, Alexandra Kuhlmann, Ping-Chih Ho, Camila Robles-Oteiza, Mmaserame Gaefele, Stellar Levy, Fernando J. de Miguel, Curtis Perry, Tianxia Guan, Gerald Krystal, William Lockwood, Daniel Zelterman, Robert Homer, Zongzhi Liu, Susan Kaech, Katerina Politi
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-15 (2019)
Abstract Background Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs) like erlotinib are effective for treating patients with EGFR mutant lung cancer; however, drug resistance inevitably emerges. Approaches to combine immunoth
Externí odkaz:
https://doaj.org/article/747919cbf484433eaa47ef5535f2fc44
Autor:
Katerina Politi, Monte M. Winslow, Dmitri A. Petrov, Heather A. Wakelee, Maximilian Diehn, Scott N. Gettinger, Robert Homer, Stellar Levy, Nicholas Rashleigh, Dylan G. Maghini, Laura Andrejka, Anna Wurtz, Jungmin Choi, Katherine Hastings, Deborah Ayeni, Wen-Yang Lin, Jessica A. Hellyer, Hongchen Cai, Chuan Li, Giorgia Foggetti
Supplementary Table
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19e796e9a84c5835ce2fd590b31071df
https://doi.org/10.1158/2159-8290.22540658
https://doi.org/10.1158/2159-8290.22540658
Autor:
Katerina Politi, Monte M. Winslow, Dmitri A. Petrov, Heather A. Wakelee, Maximilian Diehn, Scott N. Gettinger, Robert Homer, Stellar Levy, Nicholas Rashleigh, Dylan G. Maghini, Laura Andrejka, Anna Wurtz, Jungmin Choi, Katherine Hastings, Deborah Ayeni, Wen-Yang Lin, Jessica A. Hellyer, Hongchen Cai, Chuan Li, Giorgia Foggetti
Supplementary Figures
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b566697f8331848861e25b754da8421
https://doi.org/10.1158/2159-8290.22540667.v1
https://doi.org/10.1158/2159-8290.22540667.v1
Autor:
Katerina Politi, Monte M. Winslow, Dmitri A. Petrov, Heather A. Wakelee, Maximilian Diehn, Scott N. Gettinger, Robert Homer, Stellar Levy, Nicholas Rashleigh, Dylan G. Maghini, Laura Andrejka, Anna Wurtz, Jungmin Choi, Katherine Hastings, Deborah Ayeni, Wen-Yang Lin, Jessica A. Hellyer, Hongchen Cai, Chuan Li, Giorgia Foggetti
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c6f870f533b65f9ccd516f480bba96
https://doi.org/10.1158/2159-8290.22540655.v1
https://doi.org/10.1158/2159-8290.22540655.v1
Autor:
Katerina Politi, Monte M. Winslow, Dmitri A. Petrov, Heather A. Wakelee, Maximilian Diehn, Scott N. Gettinger, Robert Homer, Stellar Levy, Nicholas Rashleigh, Dylan G. Maghini, Laura Andrejka, Anna Wurtz, Jungmin Choi, Katherine Hastings, Deborah Ayeni, Wen-Yang Lin, Jessica A. Hellyer, Hongchen Cai, Chuan Li, Giorgia Foggetti
Supplementary Methods on Tuba-seq analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::168418954d74602701a0ebe6582acb49
https://doi.org/10.1158/2159-8290.22540661
https://doi.org/10.1158/2159-8290.22540661
Autor:
Katerina Politi, Monte M. Winslow, Dmitri A. Petrov, Heather A. Wakelee, Maximilian Diehn, Scott N. Gettinger, Robert Homer, Stellar Levy, Nicholas Rashleigh, Dylan G. Maghini, Laura Andrejka, Anna Wurtz, Jungmin Choi, Katherine Hastings, Deborah Ayeni, Wen-Yang Lin, Jessica A. Hellyer, Hongchen Cai, Chuan Li, Giorgia Foggetti
In lung adenocarcinoma, oncogenic EGFR mutations co-occur with many tumor suppressor gene alterations; however, the extent to which these contribute to tumor growth and response to therapy in vivo remains largely unknown. By quantifying the effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97ffcccf16114031ad1b2f6d3aa55b9
https://doi.org/10.1158/2159-8290.c.6549443.v1
https://doi.org/10.1158/2159-8290.c.6549443.v1
Autor:
Dmitri A. Petrov, Jessica A. Hellyer, Jungmin Choi, Giorgia Foggetti, Laura Andrejka, Chuan Li, Scott N. Gettinger, Deborah Ayeni, Hongchen Cai, Stellar Levy, Wen-Yang Lin, Robert J. Homer, Heather A. Wakelee, Nicholas Rashleigh, Katherine Hastings, Maximilian Diehn, Monte M. Winslow, Katerina Politi, Anna Wurtz, Dylan Maghini
Publikováno v:
Cancer Discov
In lung adenocarcinoma, oncogenic EGFR mutations co-occur with many tumor suppressor gene alterations; however, the extent to which these contribute to tumor growth and response to therapy in vivo remains largely unknown. By quantifying the effects o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e22d67bb0ab7ce573a4edcfa1b9097b
https://doi.org/10.1158/2159-8290.cd-20-1385
https://doi.org/10.1158/2159-8290.cd-20-1385
Autor:
Anna Wurtz, Jungmin Choi, Dylan Maghini, Jessica A. Hellyer, Nicholas Rashleigh, Katherine Hastings, Chuan Li, Stellar Levy, Monte M. Winslow, Wen-Yang Lin, Heather A. Wakelee, Laura Andrejka, Scott N. Gettinger, Deborah Ayeni, Dmitri A. Petrov, Giorgia Foggetti, Katerina Politi, Robert J. Homer, Hongchen Cai, Maximilian Diehn
Publikováno v:
Cancer discovery, vol 11, iss 7
Cancer genome sequencing has uncovered substantial complexity in the mutational landscape of tumors. Given this complexity, experimental approaches are necessary to establish the impact of combinations of genetic alterations on tumor biology and to u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82c280485ab2d1f7cb38f3278f1c9e0d
https://doi.org/10.1101/2020.04.13.036921
https://doi.org/10.1101/2020.04.13.036921
Autor:
Stellar Levy, Braden Miller, Curtis J. Perry, Susan M. Kaech, Alexandra Kuhlmann, Tianxia Guan, Fernando J. de Miguel, Daniel Zelterman, Camila Robles-Oteiza, Deborah Ayeni, William W. Lockwood, Ping-Chih Ho, Robert J. Homer, Katerina Politi, Mmaserame Gaefele, Gerald Krystal, Zongzhi Liu
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for immunotherapy of cancer, vol. 7, no. 1, pp. 172
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-15 (2019)
Journal for immunotherapy of cancer, vol. 7, no. 1, pp. 172
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-15 (2019)
Background Epidermal Growth Factor Receptor (EGFR) tyrosine kinase inhibitors (TKIs) like erlotinib are effective for treating patients with EGFR mutant lung cancer; however, drug resistance inevitably emerges. Approaches to combine immunotherapies a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f2f07589f052ce53139b4376d5454b5
https://pubmed.ncbi.nlm.nih.gov/31291990
https://pubmed.ncbi.nlm.nih.gov/31291990